The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.
1979; Lippincott Williams & Wilkins; Volume: 1; Issue: 4 Linguagem: Inglês
10.1161/01.hyp.1.4.416
ISSN1524-4563
AutoresJoseph M. Vinci, David L. Horwitz, Randall M. Zusman, John J. Pisano, Kevin Catt, Harry R. Keiser,
Tópico(s)Renin-Angiotensin System Studies
ResumoHomeHypertensionVol. 1, No. 4The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBThe effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. J M Vinci, D Horwitz, R M Zusman, J J Pisano, K J Catt and H R Keiser J M VinciJ M Vinci , D HorwitzD Horwitz , R M ZusmanR M Zusman , J J PisanoJ J Pisano , K J CattK J Catt and H R KeiserH R Keiser Originally published1 Jul 1979https://doi.org/10.1161/01.HYP.1.4.416Hypertension. 1979;1:416–426 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Sharma J (2010) Activation of the Bradykinin System by Angiotensin-Converting Enzyme Inhibitors, European Journal of Inflammation, 10.1177/1721727X1000800201, 8:2, (55-61), Online publication date: 1-May-2010. Carretero O, Yang X and Rhaleb N (2009) Kinins and Cardiovascular Disease Renin Angiotensin System and Cardiovascular Disease, 10.1007/978-1-60761-186-8_12, (151-185), . Azizi M, Webb R, Nussberger J and Hollenberg N (2006) Renin inhibition with aliskiren: where are we now, and where are we going?, Journal of Hypertension, 10.1097/01.hjh.0000202812.72341.99, 24:2, (243-256), Online publication date: 1-Feb-2006. Carretero O, Yang X and Rhaleb N (2005) The Kallikrein-Kinin System as a Regulator of Cardiovascular and Renal Function Hypertension, 10.1016/B978-0-7216-0258-5.50110-1, (203-218), . Cheng A and Frishman W (2013) Use of Angiotensin-Converting Enzyme Inhibitors as Monotherapy and in Combination with Diuretics and Calcium Channel Blockers, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1998.tb05784.x, 38:6, (477-491), Online publication date: 1-Jun-1998. Khaper N and Singal P (1997) Effects of Afterload-Reducing Drugs on Pathogenesis of Antioxidant Changes and Congestive Heart Failure in Rats, Journal of the American College of Cardiology, 10.1016/S0735-1097(96)00574-8, 29:4, (856-861), Online publication date: 1-Mar-1997. Sharma J, Uma K, Noor A and Rahman A (1996) Blood pressure regulation by the kallikrein-kinin system, General Pharmacology: The Vascular System, 10.1016/0306-3623(95)00028-3, 27:1, (55-63), Online publication date: 1-Jan-1996. Borghi C, Boschi S, Costa F, Bacchelli S, Esposti D, Immordino V, Piccoli M and Ambrosioni E (2009) Low Dose of ACE-Inhibitor Enhances Sodium Excretion in Volume Expanded Patients with Borderline Hypertension, Blood Pressure, 10.3109/08037059609062116, 5:2, (105-112), Online publication date: 1-Jan-1996. Ripley E, Gehr T, Kish C and Sica D (2020) Hormonal, Blood Pressure, and Peritoneal Transport Response to Short -Term Ace Inhibition, Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 10.1177/089686089401400412, 14:4, (378-383), Online publication date: 1-Oct-1994. Nielsen C and Pedersen E (1994) Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects, Journal of Internal Medicine, 10.1111/j.1365-2796.1994.tb01087.x, 235:4, (359-365), Online publication date: 1-Apr-1994. Overlack A, Adamczak M, Bachmann W, Bönner G, Bretzel R, Derichs R, Krone W, Lederle R, Reimann H, Zschiedrich H and Stumpe K (1994) ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases, The American Journal of Medicine, 10.1016/0002-9343(94)90022-1, 97:2, (126-134), Online publication date: 1-Aug-1994. Helin K, Tikkanen I, Hohenthal U and Fyhrquist F (1994) Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes, European Journal of Pharmacology, 10.1016/0014-2999(94)00450-1, 264:2, (135-141), Online publication date: 1-Oct-1994. Campbell D, Kladis A and Duncan A (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides., Hypertension, 23:4, (439-449), Online publication date: 1-Apr-1994.Campbell D, Kladis A and Duncan A (1993) Bradykinin peptides in kidney, blood, and other tissues of the rat., Hypertension, 21:2, (155-165), Online publication date: 1-Feb-1993. Sarfraz M, Jamsheed A and Preuss H (1993) Important Aspects Concerning Evaluation of Renal Function and Blood Pressure: Kinins, Prostaglandins, Lead, Clinics in Laboratory Medicine, 10.1016/S0272-2712(18)30472-4, 13:1, (235-256), Online publication date: 1-Mar-1993. Li Kam Wa T, Cooke E and Turner P (2012) A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1993.tb05663.x, 35:1, (8-13), Online publication date: 1-Jan-1993. Zusman R (1993) Angiotensin-converting enzyme inhibitors: More different than alike?, The American Journal of Cardiology, 10.1016/0002-9149(93)91052-J, 72:20, (H25-H36), Online publication date: 1-Dec-1993. Kiowski W, Linder L, Kleinbloesem C, van Brummelen P and Bühler F (1992) Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition., Circulation, 85:1, (1-8), Online publication date: 1-Jan-1992.Kumagai K, Suzuki H, Ryuzaki M, Kumagai H, Ichikawa M, Jimbo M, Matsumura Y and Saruta T (1992) Effects of antihypertensive agents on arterial baroreceptor reflexes in conscious rats., Hypertension, 20:5, (701-709), Online publication date: 1-Nov-1992. Morsi M, Madina E, Anglo A and Soliman A (1992) Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis, Acta Paediatrica, 10.1111/j.1651-2227.1992.tb12191.x, 81:2, (145-149), Online publication date: 1-Feb-1992. Hajj-ali A and Zimmerman B (1991) Kinin contribution to renal vasodilator effect of captopril in rabbit., Hypertension, 17:4, (504-509), Online publication date: 1-Apr-1991. Hall J (2014) Control of blood pressure by the renin-angiotensin-aldosterone system, Clinical Cardiology, 10.1002/clc.4960141802, 14:S4, (6-21), Online publication date: 1-Aug-1991. Guivernau M, Armijo F and Rosas R (1991) Role of sulfhydryl groups an the stimulatory effect of captopril on vascular prostacyclin synthesis, European Journal of Pharmacology, 10.1016/0014-2999(91)90554-4, 198:1, (1-6), Online publication date: 1-May-1991. Engelman R, Rousou J, Iyengar J and Das D (1991) Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction, The Annals of Thoracic Surgery, 10.1016/0003-4975(91)91256-U, 52:4, (918-926), Online publication date: 1-Oct-1991. Reams G and Bauer J (1990) Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney, Cardiovascular Drugs and Therapy, 10.1007/BF01857635, 4:1, (207-219), Online publication date: 1-Jan-1990. Anderson P, Do Y, Schambelan M, Horton R, Boger R, Luther R and Hsueh W (1990) Effects of renin inhibition in systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(90)91165-3, 66:19, (1342-1347), Online publication date: 1-Dec-1990. Sharma J (1990) Does kinin mediate the hypotensive action of angiotensin converting enzyme (ACE) inhibitors, General Pharmacology: The Vascular System, 10.1016/0306-3623(90)90697-K, 21:4, (451-457), Online publication date: 1-Jan-1990. Unger T, Gohlke P and Gruber M (1990) Converting Enzyme Inhibitors Pharmacology of Antihypertensive Therapeutics, 10.1007/978-3-642-74209-5_10, (377-481), . Brooks R, Miller K, Jones S, Burns R and Huang C (1990) Selectivity of Converting-Enzyme Inhibitors for Angiotensin I versus Bradykinin Hydrolysis Reactions, Journal of Pharmaceutical Sciences, 10.1002/jps.2600790504, 79:5, (384-388), Online publication date: 1-May-1990. Beierwaltes W and Carretero O (1989) Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis., Hypertension, 13:6_pt_2, (754-758), Online publication date: 1-Jun-1989. Iimura O and Shimamoto K (1989) Significance of Kallikrein-Kinin and Renin-Angiotensin Systems in the Hypotensive Mechanism of Angiotensin-I Converting Enzyme Inhibitors in Essential Hypertensives Kinins V, 10.1007/978-1-4615-9543-4_7, (39-48), . Waeber B, Juillerat-Jeanneret L, Aubert J, Schapira M, Nussberger J and Brunner H (2012) Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1989.tb03479.x, 27:S2, (175S-180S), Online publication date: 1-Apr-1989. Lahera V, Durán F, Cachofeiro V, Cañizo F, Cantón J, Rodriguez F and Tresguerres J (1989) Role of renal prostaglandins in the action of ramipril (HOE-498) in normotensive rats, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 10.1016/0952-3278(89)90012-4, 35:1, (25-30), Online publication date: 1-Jan-1989. Kirschenbaum M and Chaudhari A (1988) Lack of effect of captopril on preglomerular renal microvascular prostanoid biosynthesis, European Journal of Pharmacology, 10.1016/0014-2999(88)90111-2, 148:3, (335-341), Online publication date: 1-Apr-1988. Garavaglia G, Messerli F, Nunez B, Schmieder R and Frohlich E (1988) Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension, The American Journal of Cardiology, 10.1016/0002-9149(88)90892-2, 62:13, (912-916), Online publication date: 1-Nov-1988. Rotmensch H, Vlasses P and Ferguson R (1988) Angiotensin-Converting Enzyme Inhibitors, Medical Clinics of North America, 10.1016/S0025-7125(16)30776-3, 72:2, (399-425), Online publication date: 1-Mar-1988. Quilley C, Chiba S, Quilley J and McGiff J (1987) Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats., Hypertension, 10:3, (294-302), Online publication date: 1-Sep-1987. Rouse D, Dalmeida W, Williamson F and Suki W (1987) Captopril inhibits the hydroosmotic effect of ADH in the cortical collecting tubule, Kidney International, 10.1038/ki.1987.285, 32:6, (845-850), Online publication date: 1-Dec-1987. Madeddu P, Oppes M, Rubattu S, Bandiera F, Dessi'-Fulgheri P, Glorioso N, Soro A, Troffa M and Rappelli A (2009) Relation Between Urinary Kallikrein Excretion and Blood Pressure Response to a Single Oral dose of Captopril, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968709164233, 9:2-3, (615-621), Online publication date: 1-Jan-1987. Oparil S, Horton R, Wilkins L, Hammett D and Irvin J (1987) Antihypertensive Effect of Enalapril in Essential Hypertension: Role of Prostacyclin, The American Journal of the Medical Sciences, 10.1097/00000441-198712000-00001, 294:6, (395-402), Online publication date: 1-Dec-1987. Attallah A (1987) Captopril reduces renal excretion of prostaglandin E2 in the sodium-depleted rabbit, European Journal of Pharmacology, 10.1016/0014-2999(87)90370-0, 134:3, (361-363), Online publication date: 1-Feb-1987. Oparil S, Daise M, Abrahams C, Winternitz S and Szidon J (2009) Hyperoxia-induced Converting Enzyme Insufficiency in Conscious Rat: Cardiovascular Effects, Experimental Lung Research, 10.3109/01902148709068813, 12:1, (37-56), Online publication date: 1-Jan-1987. Madeddu P, Oppes M, Rubattu S, Bandiera F, Dessi'-Fulgheri P, Glorioso N, Soro A, Chiara-Troffa M and Rappelli A (1987) Urinary Kallikrein Excretion Can Predict the Blood Pressure Response to a Single Oral Dose of Captopril Vasodepressor Hormones in Hypertension: Prostaglandins and Kallikrein-Kinins, 10.1007/978-3-0348-9299-5_33, (321-328), . Tanaka S, Shimamoto K, Ando T, Nakahashi Y, Ura N, Hosoda S, Ishida H, Yamaji I, Yokoyama T, Masuda A and Iimura O (2009) Role of Renin-Angiotensin and Kallikrein-Kinin Systems on the Mechanism of the Hypotensive Effects of Converting Enzyme Inhibitor, Alacepril, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968709164231, 9:2-3, (605-609), Online publication date: 1-Jan-1987. Scherf H, Pietsch R, Landsberg G, Kramer H and Düsing R (1986) Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: Evidence for a kinin-dependent mechanism, Klinische Wochenschrift, 10.1007/BF01734341, 64:16, (742-745), Online publication date: 1-Aug-1986. De Jaegerc P, Boelaert J, Schurgers M and Daneels R (2016) Do Non-Steroidal Antiinflammatory Drugs Influence the Effects of Antihypertensive Drugs?, Acta Clinica Belgica, 10.1080/22953337.1986.11719147, 41:3, (189-198), Online publication date: 1-Jan-1986. Kudo K, Abe K, Chiba S, Omata K, Sato K, Yasugima M, Sato M and Yoshinaga K (1986) Urinary excretion of TXB2 after angiotensin converting enzyme inhibition in hypertensive patients, Prostaglandins, Leukotrienes and Medicine, 10.1016/0262-1746(86)90165-4, 21:1, (77-86), Online publication date: 1-Jan-1986. Sokolow M and Mcllroy M (1985) Hypertonie Kardiologie, 10.1007/978-3-642-69607-7_9, (247-345), . Boger J (1985) Chapter 26. Renin Inhibition , 10.1016/S0065-7743(08)61052-0, (257-266), . Haber E (1985) Defining the Physiologic and Pathophysiologic Roles of Renin: The Role of Specific Inhibitors, American Journal of Kidney Diseases, 10.1016/S0272-6386(85)80060-3, 5:4, (A14-A22), Online publication date: 1-Apr-1985. Taylor T, Moore T, Hollenberg N and Williams G (1984) Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension., Hypertension, 6:1, (92-99), Online publication date: 1-Jan-1984. Haber E (1984) From Molecular Biology to Antihypertensive Drugs: Current Research on Renin Inhibitors Nephrology, 10.1007/978-1-4612-5284-9_28, (284-301), . Sweet C and Blaine E (1984) Angiotensin-converting enzyme inhibitors Pharmacology of Antihypertensive Drugs, 10.1016/B978-0-444-90313-6.50018-6, (343-363), . Zusman R (1984) Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors, Kidney International, 10.1038/ki.1984.119, 25:6, (969-983), Online publication date: 1-Jun-1984. Carretero O and Scicli A (1984) The Glandular Kallikrein-Kinin System in Hypertension Fundamental Fault in Hypertension, 10.1007/978-94-009-5678-0_12, (158-174), . Kogure M, Ichikawa S, Sakamaki T, Matsuo H, Tajima Y, Fujita H and Murata K (2009) Hemodynamic Effects Of Captopril In One-Kidney, One Clip Hypertensive Rabbits, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968409044055, 6:5, (1035-1054), Online publication date: 1-Jan-1984. Oliver J, Sciacca R and Cannon P (1983) Renal vasodilation by converting enzyme inhibition. Role of renal prostaglandins., Hypertension, 5:2, (166-171), Online publication date: 1-Mar-1983.Holland O, von Kuhnert L, Campbell W and Anderson R (1983) Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients., Hypertension, 5:2, (235-239), Online publication date: 1-Mar-1983.Haber E, Zusman R, Burton J, Dzau V and Barger A (1983) Is renin a factor in the etiology of essential hypertension?, Hypertension, 5:6_pt_3, (V8), Online publication date: 1-Nov-1983.Weismann D, Herrig J, McWeeny O, Ayres N and Robillard J (1983) Renal and adrenal responses to hypoxemia during angiotensin-converting enzyme inhibition in lambs., Circulation Research, 52:2, (179-187), Online publication date: 1-Feb-1983. Zusman R (1983) Regulation of Prostaglandin Biosynthesis in Cultured Renal Medullary Interstitial Cells Prostaglandins and the Kidney, 10.1007/978-1-4684-4277-9_2, (17-25), . Gotoh S, Ogihara T, Nakamaru M, Higaki J, Ohde H, Tabuchi Y, Kumahara Y and Nishino T (1983) Effect of captopril on renal vascular resistance, renin, prostaglandins and kinin in the isolated perfused kidney, Life Sciences, 10.1016/0024-3205(83)90634-3, 33:24, (2409-2415), Online publication date: 1-Dec-1983. Donker A (1983) The Effect of Indomethacin on Renal Function and Glomerular Protein Loss Prostaglandins and the Kidney, 10.1007/978-1-4684-4277-9_24, (251-262), . Düsing R, Scherhag R, Landsberg G, Glänzer K and Kramer H (1983) The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta, European Journal of Pharmacology, 10.1016/0014-2999(83)90176-0, 91:4, (501-504), Online publication date: 1-Aug-1983. Mullane K, Moncada S and Vane J (1983) Does Prostaglandin Release Contribute to the Hypotension Induced by Inhibitors of Angiotensin Converting Enzyme? Prostaglandins and the Kidney, 10.1007/978-1-4684-4277-9_21, (213-233), . Rosenthal T, Stern N, Rubinstein Z, Morag B and Adar R (2016) Use of SQ 20881 Converting Enzyme Inhibitor in Predicting Response to Surgery in Renovascular Hypertension, Angiology, 10.1177/000331978203300103, 33:1, (11-16), Online publication date: 1-Jan-1982. Staessen J, Fagard R, Lijnen P and Amery A (1982) Inhibitors of the Renin-Angiotensin System as Antihypertensive Agents Hypertensive Cardiovascular Disease: Pathophysiology and Treatment, 10.1007/978-94-009-7476-0_53, (837-872), . Acosta J (1982) Hypertension in chronic renal disease, Kidney International, 10.1038/ki.1982.233, 22:6, (702-712), Online publication date: 1-Dec-1982. Swartz S and Williams G (1982) Angiotensin-converting enzyme inhibition and prostaglandins, The American Journal of Cardiology, 10.1016/0002-9149(82)90351-4, 49:6, (1405-1409), Online publication date: 1-Apr-1982. Levenson D, Simmons C and Brenner B (1982) Arachidonic acid metabolism, prostaglandins and the kidney, The American Journal of Medicine, 10.1016/0002-9343(82)90826-9, 72:2, (354-374), Online publication date: 1-Feb-1982. Carretero O and Scicli A (1981) Possible role of kinins in circulatory homeostasis. State of the art review., Hypertension, 3:3_pt_2, (I4), Online publication date: 1-May-1981.Moore T, Crantz F, Hollenberg N, Koletsky R, Leboff M, Swartz S, Levine L, Podolsky S, Dluhy R and Williams G (1981) Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension., Hypertension, 3:2, (168-173), Online publication date: 1-Mar-1981. McGiff J (1981) Prostaglandins and Hypertension Prostaglandins, Platelets, Lipids, 10.1016/B978-0-444-00566-3.50008-3, (49-73), . Golub M, Berger M, Sambhi M and Eggena P (2009) Prostaglandin and Angiotensin Converting Enzyme Inhibition: Effects on Blood Pressure, Renin Activity and Renal Function in Hemorrhaged Conscious Rabbits, Clinical and Experimental Hypertension, 10.3109/10641968109033677, 3:3, (477-495), Online publication date: 1-Jan-1981. Fujita T, Yamashita N and Yamashita K (2009) Effect of Indomethacin on Antihypertensive Action of Captopril in Hypertensive Patients, Clinical and Experimental Hypertension, 10.3109/10641968109033714, 3:5, (939-952), Online publication date: 1-Jan-1981. Fujita T, Yamashita N and Yamashita K (1981) Effects of angiotensin-converting enzyme inhibition on blood pressure and plasma renin activity in essential hypertension, American Heart Journal, 10.1016/0002-8703(81)90187-3, 101:3, (259-263), Online publication date: 1-Mar-1981. Maitra S, Scicli A, Miyazaki S and Carretero O (1981) Role of mineralocorticoid in the chronic antihypertensive effect of converting enzyme inhibitor., Hypertension, 3:2, (205-210), Online publication date: 1-Mar-1981. McGiff J, Spokas E and Wong P (1981) Prostaglandin Mechanisms in Blood Pressure Regulation and Hypertension The Prostaglandin System, 10.1007/978-1-4684-3896-3_18, (235-246), . VandenBurg M, Sharman V, Morton J, Williams G and Marsh F (1981) Hormonal and blood pressure changes during converting enzyme inhibition by teprotide., Postgraduate Medical Journal, 10.1136/pgmj.57.667.283, 57:667, (283-288), Online publication date: 1-May-1981. Williams G and Hollenberg N (1981) Hypertension and the Renin-Angiotensin-Aldosterone Axis Contemporary Nephrology, 10.1007/978-1-4615-6719-6_7, (349-388), . Goldstone R, Martin K, Zipser R and Horton R (1981) Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man, Prostaglandins, 10.1016/0090-6980(81)90068-X, 22:4, (587-598), Online publication date: 1-Oct-1981. Hockel G and Cowley A (1980) Role of the renin-angiotensin system in prostaglandin E2-induced hypertension., Hypertension, 2:4, (529-537), Online publication date: 1-Jul-1980.Meggs L and Hollenberg N (1980) Converting enzyme inhibition and the kidney., Hypertension, 2:4, (551-557), Online publication date: 1-Jul-1980.Masaki Z, Ferrario C and Bumpus F (1980) Effects of SQ 20,881 on the intact kidney of dogs with two-kidney, one clip hypertension., Hypertension, 2:5, (649-656), Online publication date: 1-Sep-1980.Mimran A, Targhetta R and Laroche B (1980) The antihypertensive effect of captopril. Evidence for an influence of kinins., Hypertension, 2:6, (732-737), Online publication date: 1-Nov-1980. Mullane K and Moncada S (1980) Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment, European Journal of Pharmacology, 10.1016/0014-2999(80)90468-9, 66:4, (355-365), Online publication date: 1-Sep-1980. McGiff J and Quilley J (2009) Prostaglandins, Kinins and the Regulation of Blood Pressure, Clinical and Experimental Hypertension, 10.3109/10641968009037139, 2:3-4, (729-740), Online publication date: 1-Jan-1980. Katz J, Williams G and Hollenberg N (1980) Plasma concentration and the depressor response to bradykinin infusion, Life Sciences, 10.1016/0024-3205(80)90306-9, 27:7, (573-576), Online publication date: 1-Aug-1980. Cushman D and Ondetti M (1980) Inhibitors of angiotensin-converting enzyme for treatment of hypertension, Biochemical Pharmacology, 10.1016/0006-2952(80)90096-9, 29:13, (1871-1877), Online publication date: 1-Jul-1980. Marin-Grez M, Bönner G and Gross F (1980) CAPTOPRIL, KALLIKREIN, AND HYPERTENSION, The Lancet, 10.1016/S0140-6736(80)91478-6, 315:8176, (1033), Online publication date: 1-May-1980. Keiser H (2009) The Kallikrein-Kinin System in Essential Hypertension, Clinical and Experimental Hypertension, 10.3109/10641968009037136, 2:3-4, (675-691), Online publication date: 1-Jan-1980. Weidmann P (1980) Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitusNeuere Aspekte zur Pathogenese der essentiellen Hypertonie und der Hypertonie bei Diabetes mellitus, Klinische Wochenschrift, 10.1007/BF01476878, 58:19, (1071-1089), Online publication date: 1-Oct-1980. Dzau V, Colucci W, Williams G, Curfman G, Meggs L and Hollenberg N (1980) Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure, New England Journal of Medicine, 10.1056/NEJM198006193022501, 302:25, (1373-1379), Online publication date: 19-Jun-1980. Hamid S, Rhaleb I, Kassem K and Rhaleb N (2020) Role of Kinins in Hypertension and Heart Failure, Pharmaceuticals, 10.3390/ph13110347, 13:11, (347) Rhaleb N, Yang X and Carretero O (2011) The Kallikrein‐Kinin System as a Regulator of Cardiovascular and Renal Function Comprehensive Physiology, 10.1002/cphy.c100053, (971-993) July 1979Vol 1, Issue 4 Advertisement Article InformationMetrics Copyright © 1979 by American Heart Associationhttps://doi.org/10.1161/01.HYP.1.4.416PMID: 232086 Originally publishedJuly 1, 1979 PDF download Advertisement
Referência(s)